Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)

Status:
Recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

This study of the efficacy and safety of Plecanatide in children 6 to <18 Years of Age with Irritable Bowel Syndrome with Constipation (IBS-C)

Phase 2

Bausch Health Americas, Inc.
Synergy Pharmaceuticals Inc.

Plecanatide